compare retatrutide and tirzepatide vs (Research Comparison) Tirzepatide vs Retatrutide for Weight
Description
Those on the GLP-1 dulaglutide were found to have a 14% risk reduction of cognitive decline compared with those on placebo
To view or add a comment, sign in While GLP-1 drugs offer substantial healthcare benefits, they can also have adverse effects
Diabetic patients treated with semaglutide (Ozempic) showed dose-dependent weight loss with an average ~6 kg at a 2 mg dose with 40% of patients losing more than 10% of their weight (1)
Yes, we provide Certificates of Analysis for our peptide products
